A direct-acting vasodilator that is used as an antihypertensive agent.
Hydralazine has been studied across 13 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🫘 Kidney, 🧠 Focus & Attention, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 48% of studies addressing this area.
This evidence profile for Hydralazine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.